PrøvGOLD- Free

Bio Spectrum  Cover - BioSpectrum Indian Feb 2025 Edition
Gold Icon

Bio Spectrum - November 2023Add to Favorites

Få ubegrenset med Magzter GOLD

Les Bio Spectrum og 9,000+ andre magasiner og aviser med bare ett abonnement  Se katalog

1 Måned $14.99

1 År$149.99

$12/måned

(OR)

Abonner kun på Bio Spectrum

1 år$11.88 $7.99

Celebrating Digital Reading - Spare 33%
Hurry! Sale ends on March 1, 2025

Kjøp denne utgaven $0.99

Gave Bio Spectrum

7-Day No Questions Asked Refund7-Day No Questions
Asked Refund Policy

 ⓘ

Digital Subscription.Instant Access.

Digitalt abonnement
Umiddelbar tilgang

Verified Secure Payment

Verifisert sikker
Betaling

I denne utgaven

AI-Driven Therapeutics for DIABETES
Diabetes mellitus, a chronic metabolic non-communicable disease (NCD), has attained epidemic proportions worldwide. Several studies conducted over the last two decades have revealed a huge burden of diabetes in India, which translates to a large population of individuals at risk of not only cardiovascular disease but also chronic complications of diabetes such as kidney, foot, and eye disease. The cost of
treating them is crippling not just individuals, but also the society and the country as a whole. For instance, diabetic foot ulcers and infections are responsible for more than 30 per cent of hospitalisations related to diabetes mellitus. On the other hand, there is a higher prevalence of diabetic retinopathy among the urban population than in the rural population. India must step up state-specific policies and technological interventions on a war footing to arrest the rapidly rising epidemic of diabetes.

Bio Spectrum Magazine Description:

Utgiver: MM Activ Sci-Tech Communication

Kategori: Business

Språk: English

Frekvens: Monthly

India's leading publication that covers the business of bio-technology. With comprehensive analyses of policy issues, products and services across the bio-pharma, bio-informatics, bio-infrastructure and bio-agriculture segments, it is the industry's most authoritative source of information.

  • cancel anytimeKanseller når som helst [ Ingen binding ]
  • digital onlyKun digitalt

Vi bruker informasjonskapsler for å tilby og forbedre tjenestene våre. Ved å bruke nettstedet vårt samtykker du til informasjonskapsler. Finn ut mer